Why Are These Stocks Trending Today?
It's Wednesday and the S&P 500 futures are still firmly in the green in pre-market trading despite the fact that the Federal Reserve is set to raise rates in its FOMC meeting for the first time in over...
Valeant Pharmaceuticals International (VRX)
Market is closed
News
- First
- << Previous
- 121 - 130
- Next >>
Why Are These Five Stocks Surging on Tuesday?
Seeing as all three indexes have surged more than 1% in morning trading as the Federal Reserve promises interest rates will still be low for a while, shares of Inland Real Estate Corporation (NYSE:IRC...
Hedge Funds Were Right to Ditch These Sinking Stocks, Part 2
We at Insider Monkey like to follow the smart money's collective sentiment, as our research has shown that we can improve our chances of outperforming the market by doing so.
Visium Asset Management Is a Staunch Supporter of These 5 Healthcare Stocks
Jacob Gottlieb’s Visium Asset Management recently filed its latest 13F with the Securities and Exchange Commission for the reporting period of September 30.
Billionaire Investors Are Betting on These Healthcare Stocks in Q4
The third quarter of 2015 was one of the worst periods that stocks from the healthcare sector have seen in the recent times.
Billionaire Bill Ackman Puts His Money Where His Mouth Is, While Carl Icahn Reveals His Newest Activist Target
The stock selection process is generally quite cumbersome and expensive on some occasions, especially when one does not have the necessary knowledge base and skills to pursue an appropriate analysis.
Jeffrey Ubben's Top 5 Q4 Stock Picks
ValueAct Capital, led by Jeffrey Ubben, recently submitted its latest 13F to the Securities and Exchange Commission for the reporting period of September 30.
Hedge Funds Are Dumping Valeant Pharmaceuticals Intl Inc (VRX); Should You?
We at Insider Monkey have gone over 700 13F filings that hedge funds and prominent investors are required to file by the government.
Four Stocks That Have Investors Buzzing Today
U.S stocks are trading in a narrow range this morning, as investors are digesting corporate news and looking for further clues as to a potential rate hike in December.
Billionaire Stephen Mandel Remains Among Valeant Bulls; Betting Big on Tech in Q4
Billionaire Stephen Mandel's Lone Pine Capital lost money in the third quarter, although three of its funds: Lone Cypress, Lone Kauri, and Lone Tamarack declined by 3.5%, 3.6%, and 3.7%, respectively...
- First
- << Previous
- 121 - 130
- Next >>
Billionaire Hedge Funds
